252 related articles for article (PubMed ID: 9186086)
1. An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy.
Shappell SB; Myrthil G; Fogo A
Am J Kidney Dis; 1997 Jun; 29(6):966-70. PubMed ID: 9186086
[No Abstract] [Full Text] [Related]
2. Kidney Biopsies in Elderly Chinese Patients: A Nationwide Survey.
Xiong M; Wang L; Liu X; Yue S; Dong J; Li Y; Su L; Wang G; Xu X; Nie S; Hou FF
Am J Kidney Dis; 2020 Aug; 76(2):295-297. PubMed ID: 32362418
[No Abstract] [Full Text] [Related]
3. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
Morel-Maroger L; Adam C; Richet G
Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
[No Abstract] [Full Text] [Related]
4. [Glomerular kidney diseases that are associated with a large clinical proteinuria and/or nephrotic syndrome].
Danilewicz M
Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s32-40. PubMed ID: 23120829
[No Abstract] [Full Text] [Related]
5. [The nephrotic syndrome caused by minimal lesions nephropathy and focal glomerulosclerosis. Morphological and clinical aspects].
Barbiano Di Belgiojoso G; Bertoli S; Busnach G; Casanova S; Dal Col A; Confalonieri R; Galato R; Micoli G; Surian M; Minetti L
Minerva Nefrol; 1981; 28(3):403-14. PubMed ID: 7329618
[No Abstract] [Full Text] [Related]
6. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
Kazi JI; Mubarak M; Ahmed E; Akhter F; Naqvi SA; Rizvi SA
Clin Exp Nephrol; 2009 Feb; 13(1):38-43. PubMed ID: 18685922
[TBL] [Abstract][Full Text] [Related]
7. Malignant nephrosis.
Gokal R; Nolph KD
Perit Dial Int; 1996; 16(5):519-27. PubMed ID: 8914182
[No Abstract] [Full Text] [Related]
8. The spectrum of glomerular diseases as studied by immunofluorescence microscopy a single center study in Iraq.
Al-Saegh RM; Assad LW
Arab J Nephrol Transplant; 2013 Sep; 6(3):161-7. PubMed ID: 24053742
[TBL] [Abstract][Full Text] [Related]
9. [The pathology of glomerulonephritis].
Thoenes W
Internist (Berl); 1989 Mar; 30(3):127-39. PubMed ID: 2654057
[No Abstract] [Full Text] [Related]
10. Relapse of nephrotic syndrome following remission for 20 years.
Cuoghi D; Vangelista A; Baraldi A; Cheli E
Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
[TBL] [Abstract][Full Text] [Related]
11. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
12. Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
Parikh RV; Tan TC; Fan D; Law D; Salyer AS; Yankulin L; Wojcicki JM; Zheng S; Ordonez JD; Chertow GM; Khoshniat-Rad F; Yang J; Go AS
PLoS One; 2021; 16(10):e0257674. PubMed ID: 34648518
[TBL] [Abstract][Full Text] [Related]
13. Glomerulonephritis Histopathological Pattern Change.
AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
[TBL] [Abstract][Full Text] [Related]
14. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
15. Serum D-dimer is a potential predictor for thromboembolism complications in patients with renal biopsy.
Tan X; Chen G; Liu Y; Zhou L; He L; Liu D; Liu Y; Zhang F; Li H; Liu H
Sci Rep; 2017 Jul; 7(1):4836. PubMed ID: 28684778
[TBL] [Abstract][Full Text] [Related]
16. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis].
Belovezhdov N
Vutr Boles; 1984; 23(4):42-6. PubMed ID: 6506660
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
Deegens JK; Wetzels JF
Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
[TBL] [Abstract][Full Text] [Related]
18. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
Brugnano R; Del Sordo R; Covarelli C; Gnappi E; Pasquali S
J Nephrol; 2016 Aug; 29(4):479-86. PubMed ID: 26842624
[TBL] [Abstract][Full Text] [Related]
19. New diagnostic tests and new therapies for glomerular diseases.
Appel GB; Appel AS
Blood Purif; 2013; 35(1-3):81-5. PubMed ID: 23343551
[TBL] [Abstract][Full Text] [Related]
20. A clinician's view of the classification of glomerulonephritis.
Cameron JS
Perspect Nephrol Hypertens; 1973; 1 Pt 1():63-79. PubMed ID: 4620928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
